Department of Pathology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Melbourne, VIC 3002, Australia.
Breast Cancer Res. 2011 Apr 26;13(2):R47. doi: 10.1186/bcr2869.
INTRODUCTION: Basal-like breast cancers behave more aggressively despite the presence of a dense lymphoid infiltrate. We hypothesised that immune suppression in this subtype may be due to T regulatory cells (Treg) recruitment driven by hypoxia-induced up-regulation of CXCR4 in Treg. METHODS: Immunoperoxidase staining for FOXP3 and CXCL12 was performed on tissue microarrays from 491 breast cancers. The hypoxia-associated marker carbonic anhydrase IX (CA9) and double FOXP3/CXCR4 staining were performed on sections from a subset of these cancers including 10 basal-like and 11 luminal cancers matched for tumour grade. RESULTS: High Treg infiltration correlated with tumour CXCL12 positivity (OR 1.89, 95% CI 1.22 to 2.94, P = 0.004) and basal phenotype (OR 3.14, 95% CI 1.08 to 9.17, P = 0.004) in univariate and multivariate analyses. CXCL12 positivity correlated with improved survival (P = 0.005), whereas high Treg correlated with shorter survival for all breast cancers (P = 0.001), luminal cancers (P < 0.001) and basal-like cancers (P = 0.040) that were confirmed in a multivariate analysis (OR 1.61, 95% CI 1.02 to 2.53, P = 0.042). In patients treated with hormone therapy, high Treg were associated with a shorter survival in a multivariate analysis (OR 1.78, 95% CI 1.01 to 3.15, P = 0.040). There was a tendency for luminal cancers to show CXCL12 expression (102/138, 74%) compared to basal-like cancers (16/27, 59%), which verged on statistical significance (P = 0.050). Up-regulation of CXCR4 in Treg correlated with the basal-like phenotype (P = 0.029) and tumour hypoxia, as indicated by CA9 expression (P = 0.049). CONCLUSIONS: Our data show that in the setting of hypoxia and CXCR4 up-regulation in Treg, CXCL12 expression may have the negative consequence of enhancing Treg recruitment and suppressing the anti-tumour immune response.
简介:尽管存在致密的淋巴浸润,基底样乳腺癌的侵袭性更强。我们假设这种亚型的免疫抑制可能是由于缺氧诱导 Treg 中 CXCR4 的上调导致 T 调节细胞(Treg)募集所致。
方法:对 491 例乳腺癌组织微阵列进行 FOXP3 和 CXCL12 的免疫过氧化物酶染色。对这些癌症的一部分进行了缺氧相关标志物碳酸酐酶 IX(CA9)和双 FOXP3/CXCR4 染色,包括 10 例基底样和 11 例管腔癌,肿瘤分级相匹配。
结果:高 Treg 浸润与肿瘤 CXCL12 阳性(OR 1.89,95%CI 1.22-2.94,P = 0.004)和基底表型(OR 3.14,95%CI 1.08-9.17,P = 0.004)相关,在单变量和多变量分析中均为阳性。CXCL12 阳性与生存改善相关(P = 0.005),而高 Treg 与所有乳腺癌(P = 0.001)、管腔癌(P < 0.001)和基底样癌(P = 0.040)的生存时间较短相关,这在多变量分析中得到证实(OR 1.61,95%CI 1.02-2.53,P = 0.042)。在接受激素治疗的患者中,高 Treg 与多变量分析中的生存时间较短相关(OR 1.78,95%CI 1.01-3.15,P = 0.040)。与基底样癌(16/27,59%)相比,管腔癌更倾向于显示 CXCL12 表达(102/138,74%),这接近统计学意义(P = 0.050)。Treg 中 CXCR4 的上调与基底样表型相关(P = 0.029),并与肿瘤缺氧相关,如 CA9 表达所示(P = 0.049)。
结论:我们的数据表明,在缺氧和 Treg 中 CXCR4 上调的情况下,CXCL12 的表达可能会通过增强 Treg 的募集并抑制抗肿瘤免疫反应而产生负面影响。
Cell Death Discov. 2025-7-24
J Mol Med (Berl). 2025-5-30
Front Oncol. 2024-11-27
J Exp Clin Cancer Res. 2024-11-28
J Clin Oncol. 2010-6-1
Clin Cancer Res. 2009-11-1
Br J Cancer. 2009-6-2
Int J Immunopathol Pharmacol. 2009